These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of COVID-19 Vaccines in SARS-CoV-2 Variants. Zhou Z; Zhu Y; Chu M Front Immunol; 2022; 13():898192. PubMed ID: 35669787 [TBL] [Abstract][Full Text] [Related]
5. A Review of the Progress and Challenges of Developing a Vaccine for COVID-19. Sharma O; Sultan AA; Ding H; Triggle CR Front Immunol; 2020; 11():585354. PubMed ID: 33163000 [TBL] [Abstract][Full Text] [Related]
6. Implication of in silico studies in the search for novel inhibitors against SARS-CoV-2. Ali F; Alom S; Shakya A; Ghosh SK; Singh UP; Bhat HR Arch Pharm (Weinheim); 2022 May; 355(5):e2100360. PubMed ID: 35244237 [TBL] [Abstract][Full Text] [Related]
7. Review of COVID-19 Vaccines and Their Evidence in Older Adults. Teo SP Ann Geriatr Med Res; 2021 Mar; 25(1):4-9. PubMed ID: 33550776 [TBL] [Abstract][Full Text] [Related]
8. Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands. Juncker HG; Mulleners SJ; Ruhé EJM; Coenen ERM; Bakker S; van Doesburg M; Harinck JE; Rood RD; Bouhuijs JH; Oomen M; de Groot PCJM; Pajkrt PD; Korosi A; van Goudoever PJB; van Gils MJ; van Keulen BJ EClinicalMedicine; 2022 May; 47():101393. PubMed ID: 35465077 [TBL] [Abstract][Full Text] [Related]
9. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection. Costanzo M; De Giglio MAR; Roviello GN Curr Med Chem; 2022; 29(1):4-18. PubMed ID: 34355678 [TBL] [Abstract][Full Text] [Related]
10. Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant. Risk M; Shen C; Hayek SS; Holevinski L; Schiopu E; Freed G; Akin C; Zhao L Clin Infect Dis; 2022 Aug; 75(1):e623-e629. PubMed ID: 35137006 [TBL] [Abstract][Full Text] [Related]
15. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
16. The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2. Jamous YF; Alhomoud DA Cureus; 2023 Sep; 15(9):e45602. PubMed ID: 37868494 [TBL] [Abstract][Full Text] [Related]
17. Review of current vaccine development platform to prevent coronavirus disease. Arif K; Malhotra S; Mohammad S; Fatima S; Farooqui S; Saleem M Natl J Maxillofac Surg; 2022; 13(3):337-346. PubMed ID: 36683946 [TBL] [Abstract][Full Text] [Related]